A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1993
12/05/1993	CA2097671A1 Heterocyclic derivatives
12/05/1993	CA2095671A1 Amino acid derivatives
12/04/1993	CA2097485A1 Thiosemicarbazone derivatives
12/04/1993	CA2097482A1 Thiosemicarbazonic acid esters
12/04/1993	CA2097462A1 Angiotensin ii antagonists
12/04/1993	CA2097460A1 Angiotensin ii antagonists
12/02/1993	DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/02/1993	DE4217963A1 Verwendung von Indolocarbazolen zur Behandlung von AIDS Use of indolocarbazoles for the treatment of AIDS
12/02/1993	DE4217842A1 Pharmaceutical compsns. for intravenous or intra-coronary admin. - are aq. emulsions contg. 1,4-di:hydro:pyridine calcium antagonist, natural oil and phosphatidyl-choline or phosphatidyl-ethanolamine
12/02/1993	DE4217396A1 Metrifonat enthaltendes Arzneimittel Metrifonate drug containing
12/02/1993	CA2358076A1 Topical patch for liposomal drug delivery system
12/01/1993	EP0572308A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/01/1993	EP0572287A2 Use of cyclic double-stranded oligonucleotides containing the binding site for a transcription factor for inhibiting gene expression
12/01/1993	EP0572259A1 Aminoquinolone derivatives as anti-HIV agents
12/01/1993	EP0572191A1 N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents
12/01/1993	EP0572190A1 Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient
12/01/1993	EP0572166A1 New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors
12/01/1993	EP0572165A1 New 7B-substituted-4-aza-5a-cholestan-ones as 5a-reductase inhibitors
12/01/1993	EP0572159A1 Medicament for the treatment of vulvar dystrophy or vaginal dryness
12/01/1993	EP0572110A2 Method of reducing or preventing toxicity associated with antiretroviral therapy by stimulation of the intracellular gluthatione level
12/01/1993	EP0572109A1 Halichondrins: Cytotoxic polyether macrolides
12/01/1993	EP0572056A1 Active principle based on avermectins, related strain and process for the preparation thereof, as well as veterinary composition containing it
12/01/1993	EP0572014A1 Hair-growing composition containing prostaglandin I 2 derivatives
12/01/1993	EP0571973A2 Slow-release sodium valproate tablets
12/01/1993	EP0571928A1 Acyclic Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
12/01/1993	EP0571903A1 A method for preparing low free formaldehyde methylol-hydantoins and compositions thereof
12/01/1993	EP0571870A1 Cyclopentane- and -pentene-beta-amino-acids
12/01/1993	EP0571822A1 Diazabicycloalkene derivatives
12/01/1993	EP0571795A1 Novel 3-phenyl-1,2,5-oxadiazoles and their use in the treatment of cardiovascular disorders, in particular angina pectoris and erectile dysfunction
12/01/1993	EP0571671A1 A Pharmaceutical composition in powder form
12/01/1993	EP0571670A1 Pharmaceutical compositions for use as mast cell stabilizer
12/01/1993	EP0571669A1 Benzenedimethanol derivatives suitable for micronisation
12/01/1993	EP0571593A1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them.
12/01/1993	EP0571575A1 Unbuffered premixed ranitidine formulation
12/01/1993	EP0571546A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity.
12/01/1993	EP0571524A1 Peroxyacid bleach precursor compositions
12/01/1993	EP0571511A1 Novel ureas and thioureas, preparation thereof and application in therapy.
12/01/1993	EP0571474A1 Orthomolecular method of treating sickle cell disease
12/01/1993	EP0571463A1 Novel cimetidine polymorph and process for preparing same
12/01/1993	EP0571462A1 Prostacycline and carbacycline derivatives as agents for treating feverish complaints
12/01/1993	EP0571387A1 A non-mitogenic competitive hgf antagonist
12/01/1993	EP0544900A4 Transdermal nicotine absorption dosage unit and process
12/01/1993	EP0541706A4 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
12/01/1993	EP0491001B1 New diphosphonic acid derivatives containing amidine groups, process for preparing them and drugs containing these compounds
12/01/1993	EP0473626B1 New diphosphonic acid derivatives, process for producing them and drugs containing them
12/01/1993	EP0429541B1 Fine-beaded colestipol hydrochloride
12/01/1993	EP0422154B1 Therapeutic use of 5-ht3 receptor antagonists
12/01/1993	EP0392006B1 Method of making a free-flowing spray-dried edible powder comprising an oil
12/01/1993	EP0236476B1 Oxygenated perfluorinated perfusion of the ocular globe
12/01/1993	CN1078970A Novel 3-fused pyridiniummethyl cephalosporins
12/01/1993	CN1078968A 2-piperazinone compounds, their production and use
12/01/1993	CN1078889A Improved pulsatile once-a-day-delivery systems for minocycline
12/01/1993	CN1078887A Method for making "Luomeishaxing" injection
12/01/1993	CN1078886A New medicine "Zhulinan" for treating prostatic hyperplasia and uropathy
12/01/1993	CN1078884A Stabilized solid pharmaceutical preparation and method of producing the same
12/01/1993	CN1022922C Process for preparing substantially anhyrous crystalline cetadroxil
12/01/1993	CN1022917C Process for 2-amino-tetrahydro-isoquinoline derivatives
12/01/1993	CN1022914C Process for preparation of 1, 3-disubstituted piperidine derivatives
12/01/1993	CA2097141A1 2,3(1h,4h)-quinoxalinediones
11/1993
11/30/1993	US5266721 Process for preparing the pure enantiomers of lifibrol and its alkyl esters
11/30/1993	US5266712 Process for crystallizing the organic substances from steroidal origin and the thus obtained compounds
11/30/1993	US5266685 Non-bitter protein hydrolyzates
11/30/1993	US5266600 Also for treatment of AIDS
11/30/1993	US5266598 Chlorhexidine digluconate, polyoxyethylene alkyl ether or alkylphenyl ether, diethanolalkanamide, amine oxide
11/30/1993	US5266596 L- or DL-threo-3-(3,4-dihydroxyphenyl)serine for the treatment of urinary incontinence
11/30/1993	US5266595 Method for treatment of cystinuria
11/30/1993	US5266594 Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity
11/30/1993	US5266592 Compositions which have a physiological cooling effect, and active compounds suitable for these compositions
11/30/1993	US5266591 Ethanolamine benzoate compounds
11/30/1993	US5266589 Method of increasing the muscle/fat ratio in agricultural domestic animals
11/30/1993	US5266588 Compound produced by a strain of microtetraspora having antibacterial and neuritogenic activity
11/30/1993	US5266582 2,4-thiazolidinedione compounds
11/30/1993	US5266581 Solid composition containing dihydropyridine, PVP and PVPP
11/30/1993	US5266580 Treatment of low pressure glaucoma and ischemic retinal degeneration with droperidol
11/30/1993	US5266578 Lipoxygenase inhibitors
11/30/1993	US5266577 Method of treating congestive heart failure using carbostyril derivatives
11/30/1993	US5266576 N-myristoyl transferase inhibitors
11/30/1993	US5266575 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
11/30/1993	US5266574 Growth regulation and related applications of opioid antagonists
11/30/1993	US5266573 Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
11/30/1993	US5266571 Treatment of hemorrhoids with 5-HT2 antagonists
11/30/1993	US5266570 Piperidine derivatives, compositions and use
11/30/1993	US5266566 Method of treating fungal infections using sterodial ester compounds
11/30/1993	US5266565 Vanadium complexes
11/30/1993	US5266564 Method for treating certain autoimmune diseases
11/30/1993	US5266560 Glucose tolerance factor
11/30/1993	US5266334 Sugar-free dry mix cellulose ether compositions as bulk laxatives
11/30/1993	US5266331 Controlled release oxycodone compositions
11/30/1993	US5266326 In situ modification of alginate
11/30/1993	US5266319 Tannin derivatives and their use for treatment of hypertension
11/30/1993	US5266318 Synergistic wound healing mixture with allantoin
11/30/1993	US5266307 Retinoic acid as a skin tanning agent in persons of light skin color
11/30/1993	CA2097258A1 Phenylfuroxans
11/30/1993	CA2097164A1 Slow-release sodium valproate tablets
11/30/1993	CA2097016A1 Pharmaceutical compounds
11/30/1993	CA2096496A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
11/30/1993	CA2070006A1 Method of decreasing excess mucus production and accumulation on the gill epithelium of aquatic animals
11/30/1993	CA1324793C 17-aza derivatives of 20, 21-dinoreburnamenine, process for their preparation and their intermediates, their application as medecines and compositions containing them
11/30/1993	CA1324792C 3(2h)pyridazinone, process for its preparation and antagonistic agent against srs-a containing it
11/30/1993	CA1324789C 20,21-dinoreburnamenin derivatives substituted in c-15 by an amino group and their salts, process for their preparation and intermediates thus obtained, their application as medicine and pharmaceutical compounds containing them

1 ... 7148 7149 7150 7151 7152 7153 7154 7155 7156 7157 7158 7159 7160 7161 7162 7163 7164 7165 7166 7167 7168 ... 7860